| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BSG | SLC2A1 | ENSVVUP00000030819 | ENSVVUP00000001976 | Basigin. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.653 |
| HK2 | INS | ENSVVUP00000005112 | ENSVVUP00000003455 | Hexokinase-2. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.604 |
| HK2 | SLC2A1 | ENSVVUP00000005112 | ENSVVUP00000001976 | Hexokinase-2. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.614 |
| HK2 | SLC2A2 | ENSVVUP00000005112 | ENSVVUP00000001429 | Hexokinase-2. | Solute carrier family 2, facilitated glucose transporter member 2 isoform X1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.467 |
| HK2 | SLC2A4 | ENSVVUP00000005112 | ENSVVUP00000039008 | Hexokinase-2. | Solute carrier family 2, facilitated glucose transporter member 4 isoform X1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.614 |
| INS | HK2 | ENSVVUP00000003455 | ENSVVUP00000005112 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Hexokinase-2. | 0.604 |
| INS | SLC2A1 | ENSVVUP00000003455 | ENSVVUP00000001976 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.734 |
| INS | SLC2A2 | ENSVVUP00000003455 | ENSVVUP00000001429 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Solute carrier family 2, facilitated glucose transporter member 2 isoform X1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.633 |
| INS | SLC2A4 | ENSVVUP00000003455 | ENSVVUP00000039008 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Solute carrier family 2, facilitated glucose transporter member 4 isoform X1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.820 |
| INS | TP53 | ENSVVUP00000003455 | ENSVVUP00000039187 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. | 0.607 |
| SLC1A1 | SLC2A1 | ENSVVUP00000009747 | ENSVVUP00000001976 | Amino acid transporter. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.742 |
| SLC1A1 | SLC2A2 | ENSVVUP00000009747 | ENSVVUP00000001429 | Amino acid transporter. | Solute carrier family 2, facilitated glucose transporter member 2 isoform X1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.422 |
| SLC1A1 | SLC38A2 | ENSVVUP00000009747 | ENSVVUP00000023334 | Amino acid transporter. | Sodium-coupled neutral amino acid transporter 2 isoform X1. | 0.611 |
| SLC1A3 | SLC2A1 | ENSVVUP00000014619 | ENSVVUP00000001976 | Amino acid transporter. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.626 |
| SLC1A3 | SLC38A2 | ENSVVUP00000014619 | ENSVVUP00000023334 | Amino acid transporter. | Sodium-coupled neutral amino acid transporter 2 isoform X1. | 0.753 |
| SLC1A5 | SLC2A1 | ENSVVUP00000000507 | ENSVVUP00000001976 | Amino acid transporter. | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | 0.743 |
| SLC1A5 | SLC38A2 | ENSVVUP00000000507 | ENSVVUP00000023334 | Amino acid transporter. | Sodium-coupled neutral amino acid transporter 2 isoform X1. | 0.611 |
| SLC2A1 | BSG | ENSVVUP00000001976 | ENSVVUP00000030819 | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | Basigin. | 0.653 |
| SLC2A1 | HK2 | ENSVVUP00000001976 | ENSVVUP00000005112 | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | Hexokinase-2. | 0.614 |
| SLC2A1 | INS | ENSVVUP00000001976 | ENSVVUP00000003455 | Solute carrier family 2, facilitated glucose transporter member 1; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.734 |